Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BEAM compared with PACB: revenue, margins and what each company keeps, and the suppliers and customers both name
BEAM
Beam Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
PACB
Pacific Biosciences of California, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BEAM
Beam Therapeutics Inc.
vs
PACB
Pacific Biosciences of California, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BEAM, solid
PACB, dashed
BEAM
Beam Therapeutics Inc.
Change
27.24
▼
−5.55%
· post 27.04
Mkt cap
$2.8B
Revenue
$490,000
Q2 FY26
Revenue
$140M
FY25
PACB
Pacific Biosciences of California, Inc.
Change
2.62
▼
−9.81%
· post 2.60
Closed
Oct 30 '26
Mkt cap
$809.7M
Revenue
$39M
Q2 FY26
Revenue
$160M
FY25
vs
Compare
Closed
Oct 30 '26
BEAM
Beam Therapeutics Inc.
vs
PACB
Pacific Biosciences of California, Inc.
27.24
▼
−5.55%
post 27.04
Price
2.62
▼
−9.81%
post 2.60
$2.8B
Mkt cap
$809.7M
Q2 FY26
$490,000
Revenue
$39M
Q2 FY26
FY25
$140M
Revenue
$160M
FY25
Change
Change
BEAM
27.24
▼
−5.55%
vs
PACB
2.62
▼
−9.81%
Closed
Oct 30 '26